tweetindex
EN

STAT ✓

@statnews · joined 24 Jul 2015

Reporting from the frontiers of health & medicine. Sign up for any of our newsletters here: https://t.co/CBx3GZBv31

165 179Followers
4 741Following
88 842Posts total
18.5KViews on collected posts

Latest posts

Why are drug overdose deaths declining? A new report points to policy measures like naloxone and harm reduction. https://t.co/cRC76zOFby 850 views · 1 likes · 0 reposts · 0 replies Open on X →
@statnews imagine denying children healthcare because you have to spend a little extra time answering hard questions from their parents 8 views · 0 likes · 0 reposts · 0 replies Open on X →
Abivax has still not been acquired. What’s going on? https://t.co/M9ZEuzSaQ8 977 views · 1 likes · 0 reposts · 0 replies Open on X →
Abivax has still not been acquired. What’s going on? https://t.co/BP2NOwohxR 1.1K views · 1 likes · 0 reposts · 0 replies Open on X →
Led by Nobel laureate David Baker and genome scientist Jay Shendure, a new $95 million effort is launching in Seattle to use AI to design biology that doesn't exist in nature: https://t.co/8v5L15vDh0 2.4K views · 3 likes · 3 reposts · 0 replies Open on X →
The pediatricians who take in vaccine-skeptical parents others won’t https://t.co/4gewvlpuoT 2.1K views · 2 likes · 0 reposts · 1 replies Open on X →
@statnews I made a different poster for you guys because same shit different poster.. https://t.co/e4Pw5uMara
66 views · 0 likes · 0 reposts · 0 replies Open on X →
@statnews $nwbo unbelievable phase lll results in 2022. Waiting for @MHRAgovuk approval anyday. Works on ALL solid tumor cancers. No side effects. 2.3K views · 43 likes · 5 reposts · 3 replies Open on X →
A personalized mRNA cancer vaccine succeeded in a late-stage melanoma study, results that could herald a new, powerful approach in oncology. https://t.co/rFgy8zqSIq 8.7K views · 34 likes · 8 reposts · 2 replies Open on X →

Against accounts of the same size

9 posts from the last 90 days, next to the 100K–1M follower range. below its peers on both reach and engagement.

Median views1 063this account5 983median for 100K–1M
Reach, %0.64%this account1.49%median for 100K–1M
Engagement, %0.12%this account0.93%median for 100K–1M
MetricThis accountMedian for 100K–1MRatio
Median views per post1 0635 9830.18×
Reach (views ÷ followers)0.64%1.49%0.43×
Engagement rate0.12%0.93%0.13×

Others in this range →   Compare with another account →   How these benchmarks are built →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

8.7K19 Aug
2.3K
66
2.1K3 Sep
2.4K
1.1K
977
8
850

Last 9 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.56%19 Aug
2.33%
0.00%
0.14%3 Sep
0.25%
0.09%
0.10%
0.00%
0.12%

Reactions — likes, reposts, replies and quotes — divided by views. Median for 100K–1M accounts is 0.93%.

What the audience does

Likes69.1%85 in total
Reposts13.0%16 in total
Replies4.9%6 in total
Quotes5.7%7 in total
Bookmarks7.3%9 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Similar accounts